Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Abrocitinib may effectively treat stubborn alopecia universalis.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.

Genetic variants in PDE6H and LPAR6 cause vision impairment and hair loss in two Pakistani brothers.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alkaline phosphatase activity decreases in early alopecia areata.

Oral zinc gluconate and topical steroids significantly improved a rare scalp condition in three elderly patients.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Pili annulati is caused by a protein metabolism disorder affecting hair structure.

The grand round helps improve diagnoses and suggests new treatments for hair disorders.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

A 12-year-old girl was misdiagnosed with alopecia areata but actually had a nevus sebaceus with a genetic mutation.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Alopecia areata often appears on the scalp and is linked to various health issues, needing thorough evaluation.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

DHT increases scalp heat, causing hair loss.